Huotari, M
A programme with support includes regular clinical reviews to adjust the dose, plus a registered dietitian or coach to help manage side effects, nutrition, and habits that help prevent future weight regain
Living with the unpredictable and often invisible symptoms of Long COVID, ME/CFS, and dysautonomia can be an incredibly isolating and frustrating experience
Interactions between symptoms and psychological status in irritable bowel syndrome: An exploratory study of the impact of a probiotic combination
Whether it is BPC157 for tendonitis, ACL recovery, or joint pain relief, consistent use can lead to visible improvements in tissue repair and overall wellness
Results: The 18-month risk for ION was 8.5 versus 5.5 per 10 000 among GLP-1RA users versus SGLT2i users (RD, 3.0 [95% CI, 0.4 to 5.7]) and 7.8 versus 4.2 per 10 000 among GLP-1RA users versus DPP4i users (RD, 3.6 [CI, 1.1 to 6.1])